ERJ January Podcast: The RESPIRE trials
Eur Respir J, 51 (1) 18E5101; 10.1183/13993003.E5101-2018 | |
Turning thirty: evolution but not revolution at the ERJ Martin Kolb, James D. Chalmers Eur Respir J, 51 (1) 1702594; 10.1183/13993003.02594-2017 | |
Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network James D. Chalmers, Felix C. Ringshausen, Bridget Harris, J. Stuart Elborn, Annette Posthumus, Charles S. Haworth, Nicola Pilkington, Eva Polverino, Thomas Ruddy, Stefano Aliberti, Pieter C. Goeminne, Craig Winstanley, Anthony De Soyza Eur Respir J, 51 (1) 1701937; 10.1183/13993003.01937-2017 | |
Looking for a chronic care model in COPD patients Enrico Clini, Ivana Castaniere, Roberto Tonelli Eur Respir J, 51 (1) 1702087; 10.1183/13993003.02087-2017 | |
Time for a longer and better life for patients with COPD Lowie E.G.W. Vanfleteren, Anders Ullman, Leonardo M. Fabbri Eur Respir J, 51 (1) 1702569; 10.1183/13993003.02569-2017 | |
Inspiratory muscle training in stable COPD patients: enough is enough? Nicolino Ambrosino Eur Respir J, 51 (1) 1702285; 10.1183/13993003.02285-2017 | |
Breath analysis for label-free characterisation of airways disease Stephen J. Fowler Eur Respir J, 51 (1) 1702586; 10.1183/13993003.02586-2017 | |
Inhaler adherence in severe asthma: is there an electronic solution? Mina Gaga, Konstantinos Samitas, Eleftherios Zervas Eur Respir J, 51 (1) 1702219; 10.1183/13993003.02219-2017 | |
The inhaled corticosteroid/long-acting ß-agonist maintenance and reliever therapy regimen: where to from here? Richard Beasley, Irene Braithwaite, James Fingleton, Mark Weatherall Eur Respir J, 51 (1) 1702338; 10.1183/13993003.02338-2017 | |
How does inflammation contribute to pulmonary hypertension? Rahul Kumar, Brian Graham Eur Respir J, 51 (1) 1702403; 10.1183/13993003.02403-2017 | |
ELTGOL airway clearance in bronchiectasis: laying the bricks of evidence Conroy Wong, Cameron Sullivan, Lata Jayaram Eur Respir J, 51 (1) 1702232; 10.1183/13993003.02232-2017 | |
RESPIRE: breathing new life into bronchiectasis Sanjay H. Chotirmall, James D. Chalmers Eur Respir J, 51 (1) 1702444; 10.1183/13993003.02444-2017 | |
The unmet medical need of pulmonary hypertension in idiopathic pulmonary fibrosis Vincent Cottin, Laura C. Price, Claudia Valenzuela Eur Respir J, 51 (1) 1702596; 10.1183/13993003.02596-2017 | |
The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy? Christopher J. Ryerson, Martin Kolb Eur Respir J, 51 (1) 1702420; 10.1183/13993003.02420-2017 | |
Is chronic exposure to air pollutants a risk factor for the development of idiopathic pulmonary fibrosis? Valérie Siroux, Bruno Crestani Eur Respir J, 51 (1) 1702663; 10.1183/13993003.02663-2017 | |
It's time to evolve from Scadding: phenotyping sarcoidosis Daniel A. Culver, Robert P. Baughman Eur Respir J, 51 (1) 1800050; 10.1183/13993003.00050-2018 | |
ERS/ATS workshop report on respiratory health effects of household air pollution Akshay Sood, Nour A. Assad, Peter J. Barnes, Andrew Churg, Stephen B. Gordon, Kevin S. Harrod, Hammad Irshad, Om P. Kurmi, William J. Martin, Paula Meek, Kevin Mortimer, Curtis W. Noonan, Rogelio Perez-Padilla, Kirk R. Smith, Yohannes Tesfaigzi, Tony Ward, John Balmes Eur Respir J, 51 (1) 1700698; 10.1183/13993003.00698-2017 | |
Effects of the “Living well with COPD” intervention in primary care: a comparative study Claudia Steurer-Stey, Kaba Dalla Lana, Julia Braun, Gerben ter Riet, Milo A. Puhan Eur Respir J, 51 (1) 1701375; 10.1183/13993003.01375-2017 | |
Program of Integrated Care for Patients with Chronic Obstructive Pulmonary Disease and Multiple Comorbidities (PIC COPD+): a randomised controlled trial Louise Rose, Laura Istanboulian, Lise Carriere, Anna Thomas, Han-Byul Lee, Shaghayegh Rezaie, Roshan Shafai, Ian Fraser Eur Respir J, 51 (1) 1701567; 10.1183/13993003.01567-2017 | |
COMET: a multicomponent home-based disease-management programme versus routine care in severe COPD Romain Kessler, Pere Casan-Clara, Dieter Koehler, Silvia Tognella, Jose Luis Viejo, Roberto W. Dal Negro, Salvador Díaz-Lobato, Karina Reissig, José Miguel Rodríguez González-Moro, Gilles Devouassoux, Jean-Michel Chavaillon, Pierre Botrus, Jean-Michel Arnal, Julio Ancochea, Anne Bergeron-Lafaurie, Carlos De Abajo, Winfried J. Randerath, Andreas Bastian, Christian G. Cornelissen, Georg Nilius, Joëlle B. Texereau, Jean Bourbeau Eur Respir J, 51 (1) 1701612; 10.1183/13993003.01612-2017 | |
Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD Bernardino Alcázar-Navarrete, Oliverio Ruiz Rodríguez, Pablo Conde Baena, Pedro José Romero Palacios, Alvar Agusti Eur Respir J, 51 (1) 1701457; 10.1183/13993003.01457-2017 | |
Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial Konrad Schultz, Danijel Jelusic, Michael Wittmann, Benjamin Krämer, Veronika Huber, Sebastian Fuchs, Nicola Lehbert, Silke Wingart, Dragan Stojanovic, Oliver Göhl, Harma J. Alma, Corina de Jong, Thys van der Molen, Hermann Faller, Michael Schuler Eur Respir J, 51 (1) 1702000; 10.1183/13993003.02000-2017 | |
Effects of inspiratory muscle training on dyspnoea in severe COPD patients during pulmonary rehabilitation: controlled randomised trial Marc Beaumont, Philippe Mialon, Catherine Le Ber, Patricia Le Mevel, Loïc Péran, Olivier Meurisse, Capucine Morelot-Panzini, Angelina Dion, Francis Couturaud Eur Respir J, 51 (1) 1701107; 10.1183/13993003.01107-2017 | |
Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label Rianne de Vries, Yennece W.F. Dagelet, Pien Spoor, Erik Snoey, Patrick M.C. Jak, Paul Brinkman, Erica Dijkers, Simon K. Bootsma, Fred Elskamp, Frans H.C. de Jongh, Eric G. Haarman, Johannes C.C.M in ‘t Veen, Anke-Hilse Maitland-van der Zee, Peter J. Sterk Eur Respir J, 51 (1) 1701817; 10.1183/13993003.01817-2017 | |
A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma Imran Sulaiman, Garrett Greene, Elaine MacHale, Jansen Seheult, Matshediso Mokoka, Shona D'Arcy, Terence Taylor, Desmond M. Murphy, Eoin Hunt, Stephen J. Lane, Gregory B. Diette, J. Mark FitzGerald, Fiona Boland, Aoife Sartini Bhreathnach, Breda Cushen, Richard B. Reilly, Frank Doyle, Richard W. Costello Eur Respir J, 51 (1) 1701126; 10.1183/13993003.01126-2017 | |
Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma Carin Jorup, Dan Lythgoe, Hans Bisgaard Eur Respir J, 51 (1) 1701688; 10.1183/13993003.01688-2017 | |
Inhaled diesel exhaust alters the allergen-induced bronchial secretome in humans Neeloffer Mookherjee, Hadeesha Piyadasa, Min Hyung Ryu, Christopher Francis Rider, Peyman Ezzati, Victor Spicer, Christopher Carlsten Eur Respir J, 51 (1) 1701385; 10.1183/13993003.01385-2017 | |
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial Cécile Tromeur, Olivier Sanchez, Emilie Presles, Gilles Pernod, Laurent Bertoletti, Patrick Jego, Elisabeth Duhamel, Karine Provost, Florence Parent, Philippe Robin, Lucile Deloire, Florent Leven, Fanny Mingant, Luc Bressollette, Pierre-Yves Le Roux, Pierre-Yves Salaun, Michel Nonent, Brigitte Pan-Petesch, Benjamin Planquette, Philippe Girard, Karine Lacut, Solen Melac, Patrick Mismetti, Silvy Laporte, Guy Meyer, Dominique Mottier, Christophe Leroyer, Francis Couturaud Eur Respir J, 51 (1) 1701202; 10.1183/13993003.01202-2017 | |
The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension Leigh M. Marsh, Katharina Jandl, Gabriele Grünig, Vasile Foris, Mina Bashir, Bahil Ghanim, Walter Klepetko, Horst Olschewski, Andrea Olschewski, Grazyna Kwapiszewska Eur Respir J, 51 (1) 1701214; 10.1183/13993003.01214-2017 | |
Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial Gerard Muñoz, Javier de Gracia, Maria Buxó, Antonio Alvarez, Montserrat Vendrell Eur Respir J, 51 (1) 1701926; 10.1183/13993003.01926-2017 | |
RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis Anthony De Soyza, Timothy Aksamit, Tiemo-Joerg Bandel, Margarita Criollo, J. Stuart Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin L. Winthrop, Robert Wilson Eur Respir J, 51 (1) 1702052; 10.1183/13993003.02052-2017 | |
RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis Timothy Aksamit, Anthony De Soyza, Tiemo-Joerg Bandel, Margarita Criollo, J. Stuart Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin L. Winthrop, Robert Wilson Eur Respir J, 51 (1) 1702053; 10.1183/13993003.02053-2017 | |
Predicting response to oxygen therapy in obstructive sleep apnoea patients using a 10-minute daytime test David Wang, Keith K. Wong, Luke Rowsell, Garrick W. Don, Brendon J. Yee, Ronald R. Grunstein Eur Respir J, 51 (1) 1701587; 10.1183/13993003.01587-2017 | |
The impact of digital health technologies on tuberculosis treatment: a systematic review Brian Kermu Ngwatu, Ntwali Placide Nsengiyumva, Olivia Oxlade, Benjamin Mappin-Kasirer, Nhat Linh Nguyen, Ernesto Jaramillo, Dennis Falzon, Kevin Schwartzman Eur Respir J, 51 (1) 1701596; 10.1183/13993003.01596-2017 | |
National roll-out of latent tuberculosis testing and treatment for new migrants in England: a retrospective evaluation in a high-incidence area Miranda G. Loutet, Matthew Burman, Nivenka Jayasekera, Duncan Trathen, Susan Dart, Heinke Kunst, Dominik Zenner Eur Respir J, 51 (1) 1701226; 10.1183/13993003.01226-2017 | |
Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease Carlos Acuña-Villaorduña, Edward C. Jones-López, Geisa Fregona, Patricia Marques-Rodrigues, Mary Gaeddert, Carolina Geadas, David Jamil Hadad, Laura F. White, Lucilia Pereira Dutra Molina, Solange Vinhas, Rodrigo Ribeiro-Rodrigues, Padmini Salgame, Moises Palaci, David Alland, Jerrold J. Ellner, Reynaldo Dietze Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017 | |
A scoring system to predict the elevation of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis Taiki Furukawa, Yasuhiro Kondoh, Hiroyuki Taniguchi, Mitsuaki Yagi, Toshiaki Matsuda, Tomoki Kimura, Kensuke Kataoka, Takeshi Johkoh, Masahiko Ando, Naozumi Hashimoto, Koji Sakamoto, Yoshinori Hasegawa Eur Respir J, 51 (1) 1701311; 10.1183/13993003.01311-2017 | |
Neurophysiological mechanisms of exertional dyspnoea in fibrotic interstitial lung disease Michele R. Schaeffer, Christopher J. Ryerson, Andrew H. Ramsook, Yannick Molgat-Seon, Sabrina S. Wilkie, Satvir S. Dhillon, Reid A. Mitchell, A. William Sheel, Nasreen Khalil, Pat G. Camp, Jordan A. Guenette Eur Respir J, 51 (1) 1701726; 10.1183/13993003.01726-2017 | |
Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001–2013 Dominic C. Marshall, Justin D. Salciccioli, Barry S. Shea, Praveen Akuthota Eur Respir J, 51 (1) 1701603; 10.1183/13993003.01603-2017 | |
Dasatinib increases endothelial permeability leading to pleural effusion Carole Phan, Etienne-Marie Jutant, Ly Tu, Raphaël Thuillet, Andrei Seferian, David Montani, Alice Huertas, Jan van Bezu, Fabian Breijer, Anton Vonk Noordegraaf, Marc Humbert, Jurjan Aman, Christophe Guignabert Eur Respir J, 51 (1) 1701096; 10.1183/13993003.01096-2017 | |
The association between air pollution and the incidence of idiopathic pulmonary fibrosis in Northern Italy Sara Conti, Sergio Harari, Antonella Caminati, Antonella Zanobetti, Joel D. Schwartz, Pietro A. Bertazzi, Giancarlo Cesana, Fabiana Madotto Eur Respir J, 51 (1) 1700397; 10.1183/13993003.00397-2017 | |
Phenotypes of organ involvement in sarcoidosis Jonas Christian Schupp, Sandra Freitag-Wolf, Elena Bargagli, Violeta Mihailovic-Vucinic, Paola Rottoli, Aleksandar Grubanovic, Annegret Müller, Arne Jochens, Lukas Tittmann, Jasmin Schnerch, Carmela Olivieri, Annegret Fischer, Dragana Jovanovic, Snežana Filipovic, Jelica Videnovic-Ivanovic, Paul Bresser, René Jonkers, Kate O'Reilly, Ling-Pei Ho, Karoline I. Gaede, Peter Zabel, Anna Dubaniewicz, Ben Marshall, Robert Kieszko, Janusz Milanowski, Andreas Günther, Anette Weihrich, Martin Petrek, Vitezslav Kolek, Michael P. Keane, Sarah O'Beirne, Seamas Donnelly, Sigridur Olina Haraldsdottir, Kristin B. Jorundsdottir, Ulrich Costabel, Francesco Bonella, Benoît Wallaert, Christian Grah, Tatjana Peroš-Golubicic, Mauritio Luisetti, Zamir Kadija, Stefan Pabst, Christian Grohé, János Strausz, Martina Vašáková, Martina Sterclova, Ann Millar, Jirí Homolka, Alena Slováková, Yvonne Kendrick, Anjali Crawshaw, Wim Wuyts, Lisa Spencer, Michael Pfeifer, Dominique Valeyre, Venerino Poletti, Hubertus Wirtz, Antje Prasse, Stefan Schreiber, Michael Krawczak, Joachim Müller-Quernheim Eur Respir J, 51 (1) 1700991; 10.1183/13993003.00991-2017 | |
Observational, multicentre study on the epidemiology of haemoptysis Michele Mondoni, Paolo Carlucci, Sara Job, Elena Maria Parazzini, Giuseppe Cipolla, Matteo Pagani, Francesco Tursi, Luigi Negri, Alessandro Fois, Sara Canu, Antonella Arcadu, Pietro Pirina, Martina Bonifazi, Stefano Gasparini, Silvia Marani, Andrea Claudio Comel, Franco Ravenna, Simone Dore, Fausta Alfano, Giuseppe Francesco Sferrazza Papa, Fabiano Di Marco, Stefano Centanni, Giovanni Sotgiu Eur Respir J, 51 (1) 1701813; 10.1183/13993003.01813-2017 | |
Baclofen and sleep apnoea syndrome: analysis of VigiBase, the WHO pharmacovigilance database Bruno Revol, Ingrid Jullian-Desayes, Sébastien Bailly, Michel Mallaret, Renaud Tamisier, Marie-Sara Agier, Frédéric Lador, Marie Joyeux-Faure, Jean-Louis Pépin Eur Respir J, 51 (1) 1701855; 10.1183/13993003.01855-2017 | |
Tuberculosis elimination: a dream or a reality? The case of Oman Fatma Al Yaquobi, Seif Al-Abri, Bader Al-Abri, Idris Al-Abaidani, Amina Al-Jardani, Lia D'Ambrosio, Rosella Centis, Alberto Matteelli, Davide Manissero, Giovanni Battista Migliori Eur Respir J, 51 (1) 1702027; 10.1183/13993003.02027-2017 | |
Cigarette smoking and response to inhaled corticosteroids in COPD Surya P. Bhatt, Julie A. Anderson, Robert D. Brook, Peter M.A. Calverley, Bartolome R. Celli, Nicholas J. Cowans, Courtney Crim, Fernando J. Martinez, David E. Newby, Jørgen Vestbo, Julie C. Yates, Mark T. Dransfield Eur Respir J, 51 (1) 1701393; 10.1183/13993003.01393-2017 | |
Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis Caroline E. Broos, Monique Wapenaar, Caspar W.N. Looman, Johannes C.C.M. in ’t Veen, Leon M. van den Toorn, Maria J. Overbeek, Marco J.J.H. Grootenboers, Roxane Heller, Rémy L. Mostard, Linda H.C. Poell, Henk C. Hoogsteden, Mirjam Kool, Marlies S. Wijsenbeek, Bernt van den Blink Eur Respir J, 51 (1) 1702089; 10.1183/13993003.02089-2017 | |
Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials Stefano Barco, Eric Vicaut, Frederikus A. Klok, Mareike Lankeit, Guy Meyer, Stavros V. Konstantinides Eur Respir J, 51 (1) 1701775; 10.1183/13993003.01775-2017 | |
Tuberculosis and tobacco: is there any epidemiological association? Eva Padrão, Olena Oliveira, Óscar Felgueiras, Ana Rita Gaio, Raquel Duarte Eur Respir J, 51 (1) 1702121; 10.1183/13993003.02121-2017 | |
Both moderate and severe exacerbations accelerate physical activity decline in COPD patients Heleen Demeyer, Marcos Costilla-Frias, Zafeiris Louvaris, Elena Gimeno-Santos, Maggie Tabberer, Roberto A. Rabinovich, Corina de Jong, Michael I. Polkey, Nicholas S. Hopkinson, Niklas Karlsson, Ignasi Serra, Ioannis Vogiatzis, Thierry Troosters, Judith Garcia-Aymerich Eur Respir J, 51 (1) 1702110; 10.1183/13993003.02110-2017 | |
Eosinophils in COPD: how many swallows make a summer? Ghassan Ahmed Hamad, Wesley Cheung, Michael G. Crooks, Alyn H. Morice Eur Respir J, 51 (1) 1702177; 10.1183/13993003.02177-2017 | |
Immunotherapy and pulmonary toxicities: can concomitant immune-checkpoint inhibitors with radiotherapy increase the risk of radiation pneumonitis? Guillaume Louvel, Rastislav Bahleda, Samy Ammari, Cécile Le Péchoux, Antonin Levy, Christophe Massard, Jérôme Le Pavec, Stéphane Champiat, Eric Deutsch Eur Respir J, 51 (1) 1701737; 10.1183/13993003.01737-2017 | |
The effects of 100% oxygen on breathing pattern are not limited to young children Courtney Moore, Eric Horton, Nick Benseler, Renee Jensen, Felix Ratjen Eur Respir J, 51 (1) 1702055; 10.1183/13993003.02055-2017 | |
Macrolides, mucoactive drugs and adherence for the management of bronchiectasis Wei-jie Guan, Yan Huang, Chun-lan Chen, Rong-chang Chen, Nan-shan Zhong Eur Respir J, 51 (1) 1701987; 10.1183/13993003.01987-2017 | |
Macrolides, mucoactive drugs and adherence for the management of bronchiectasis James D. Chalmers, Eva Polverino Eur Respir J, 51 (1) 1702033; 10.1183/13993003.02033-2017 | |
Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future? Martijn A. Spruit, Sally J. Singh, Carolyn L. Rochester, Neil J. Greening, Frits M.E. Franssen, Fabio Pitta, Thierry Troosters, Claire Nolan, Ioannis Vogiatzis, Enrico M. Clini, William D-C. Man, Chris Burtin, Roger S. Goldstein, Lowie E.G.W. Vanfleteren, Klaus Kenn, Linda Nici, Daisy J.A. Janssen, Richard Casaburi, Takanobu Shioya, Chris Garvey, Brian W. Carlin, Richard L. ZuWallack, Michael Steiner, Emiel F.M. Wouters, Milo A. Puhan Eur Respir J, 51 (1) 1701312; 10.1183/13993003.01312-2017 | |
Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future? Kevin C. Wilson, Jerry A. Krishnan, Pawel Sliwinski, Gerard J. Criner, Marc Miravitlles, John R. Hurst, Peter M.A. Calverley, Richard K. Albert, David Rigau, Thomy Tonia, Jørgen Vestbo, Alberto Papi, Klaus F. Rabe, Antonio Anzueto, Jadwiga A. Wedzicha Eur Respir J, 51 (1) 1702577; 10.1183/13993003.02577-2017 | |
Lack of penetration of amikacin into saliva of tuberculosis patients Simone H.J. van den Elsen, Onno W. Akkerman, Justine R. Huisman, Daan J. Touw, Tjip S. van der Werf, Mathieu S. Bolhuis, Jan-Willem C. Alffenaar Eur Respir J, 51 (1) 1702024; 10.1183/13993003.02024-2017 | |
Balloon pulmonary angioplasty in sarcoid-related pulmonary hypertension Jelco Tramper, Esther J. Nossent, Rutger J. Lely, Frans H. Krouwels, Lilian J. Meijboom, Anton Vonk Noordegraaf Eur Respir J, 51 (1) 1701502; 10.1183/13993003.01502-2017 | |
Can YKL-40 be used as a biomarker and therapeutic target for adult asthma? Xiang Tong, Dongguang Wang, Sitong Liu, Yao Ma, Hong Fan Eur Respir J, 51 (1) 1702194; 10.1183/13993003.02194-2017 | |
Chronic breathlessness: re-thinking the symptom Olivia K. Faull, Lucy Marlow, Sarah L. Finnegan, Kyle T.S. Pattinson Eur Respir J, 51 (1) 1702238; 10.1183/13993003.02238-2017 | |
Chronic breathlessness: re-thinking the symptom Miriam J. Johnson, Janelle Yorke, John Hansen-Flaschen, Robert Lansing, Magnus Ekström, David C. Currow Eur Respir J, 51 (1) 1702326; 10.1183/13993003.02326-2017 | |
Chronic breathlessness: re-thinking the symptom Jane Macnaughton, Rebecca Oxley, Arthur Rose, Andrew Russell, James W. Dodd, Havi Carel Eur Respir J, 51 (1) 1702331; 10.1183/13993003.02331-2017 | |
European Respiratory Journal, list of peer reviewers 2017
Eur Respir J, 51 (1) 1815101; 10.1183/13993003.15101-2018 | |
“An official European Respiratory Society statement: pulmonary haemodynamics during exercise.” Gabor Kovacs, Philippe Herve, Joan Albert Barbera, Ari Chaouat, Denis Chemla, Robin Condliffe, Gilles Garcia, Ekkehard Grünig, Luke Howard, Marc Humbert, Edmund Lau, Pierantonio Laveneziana, Gregory D. Lewis, Robert Naeije, Andrew Peacock, Stephan Rosenkranz, Rajeev Saggar, Silvia Ulrich, Dario Vizza, Anton Vonk Noordegraaf and Horst Olschewski. Eur Respir J 2017; 50: 1700578.
Eur Respir J, 51 (1) 1750578; 10.1183/13993003.50578-2017 | |